Sotera Health Company (NASDAQ:SHC) Stock Has Consensus Price Target of $21.38 According to Analysts

Sotera Health Company (NASDAQ:SHC) has been assigned an average recommendation of “Moderate Buy” from the eleven research firms that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eight have given a buy rating to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $21.38.

SHC has been the topic of several research analyst reports. Citigroup lifted their price objective on Sotera Health from $23.00 to $25.00 and gave the stock a “buy” rating in a report on Friday, August 7th. Weiss Ratings cut Sotera Health from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday. Barclays increased their target price on Sotera Health from $19.00 to $22.00 and gave the company an “overweight” rating in a report on Friday, August 7th. Piper Sandler restated an “overweight” rating and issued a $25.00 target price on shares of Sotera Health in a research report on Tuesday, September 8th. Finally, Wall Street Zen raised Sotera Health from a “buy” rating to a “strong-buy” rating in a research note on Sunday.

Sotera Health Stock Up 1.6%

Shares of NASDAQ SHC opened at $18.39 on Tuesday. The firm has a market cap of $5.25 billion, a price-to-earnings ratio of 21.29 and a beta of 1.85. The company’s 50-day simple moving average is $18.56 and its 200-day simple moving average is $17.05. The company has a quick ratio of 2.55, a current ratio of 2.80 and a debt-to-equity ratio of 3.33. Sotera Health has a 52-week low of $13.09 and a 52-week high of $19.85.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.02. The firm had revenue of $321.38 million during the quarter, compared to the consensus estimate of $309.70 million. Sotera Health had a net margin of 13.44% and a return on equity of 40.12%. The company’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.20 EPS. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. Equities analysts predict that Sotera Health will post 0.87 EPS for the current fiscal year.

Insider Buying and Selling at Sotera Health

In other Sotera Health news, insider Michael Rutz sold 150,000 shares of Sotera Health stock in a transaction on Friday, August 7th. The shares were sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the sale, the insider owned 334,279 shares of the company’s stock, valued at $6,297,816.36. The trade was a 30.97% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Chairman Michael Petras, Jr. sold 850,000 shares of Sotera Health stock in a transaction on Monday, August 17th. The stock was sold at an average price of $18.50, for a total transaction of $15,725,000.00. Following the sale, the chairman directly owned 3,969,393 shares in the company, valued at approximately $73,433,770.50. This trade represents a 17.64% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 1,294,515 shares of company stock valued at $23,999,528. 15.36% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Sotera Health

A number of hedge funds have recently modified their holdings of SHC. Root Financial Partners LLC lifted its stake in shares of Sotera Health by 217.5% in the first quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock worth $30,000 after buying an additional 1,455 shares in the last quarter. Meeder Asset Management Inc. acquired a new position in Sotera Health during the second quarter worth about $37,000. Nykredit A S purchased a new stake in Sotera Health during the 2nd quarter valued at about $50,000. IFP Advisors Inc grew its stake in Sotera Health by 150.8% during the 2nd quarter. IFP Advisors Inc now owns 3,509 shares of the company’s stock valued at $62,000 after acquiring an additional 2,110 shares in the last quarter. Finally, Strs Ohio grew its stake in Sotera Health by 20.1% during the 1st quarter. Strs Ohio now owns 5,881 shares of the company’s stock valued at $84,000 after acquiring an additional 986 shares in the last quarter. 91.03% of the stock is currently owned by institutional investors and hedge funds.

About Sotera Health

Sotera Health Company (NASDAQ: SHC) is a healthcare services company focused on sterilization, laboratory testing and infection prevention. Its services support manufacturers and providers across the medical device, pharmaceutical, tissue, food safety and other healthcare-related industries.

The company operates through three primary businesses. Sterigenics provides outsourced sterilization services, including ethylene oxide, gamma irradiation and electron-beam processing. Nelson Labs offers laboratory testing, analytical services and consulting for medical devices, pharmaceuticals and other healthcare products.